1. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model

   • Jin Young Yoo
   • Seung-Ho Yang
   • Sang Won Lee

   Laboratory Investigation 11 May 2012 Pages: 219 - 227

   

2. Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer

   • Jun Huang
   • Yan Michael Li
   • Walter A. Hall

   Laboratory Investigation 14 June 2012 Pages: 229 - 238

   

3. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma

   • Alexander Baraniskin
   • Jan Kuhnhenn
   • Roland Schroers

   Laboratory Investigation 23 June 2012 Pages: 239 - 244

   

4. Isthmin inhibits glioma growth through antiangiogenesis in vivo

   • Bangqing Yuan
   • Ronghua Xian
   • Yaoming Song

   Laboratory Investigation Open access 07 July 2012 Pages: 245 - 252

   

5. IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma

   • Ying Liu
   • Wenqing Jiang
   • Yin Wang

   Laboratory Investigation 08 July 2012 Pages: 253 - 260

   

6. Genetic characterization of gliomas arising in patients with multiple sclerosis

   • Adam Khalil
   • Hilary Serracino
   • B. K. Kleinschmidt-DeMasters

   Clinical Study 01 May 2012 Pages: 261 - 272

   

7. Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome

   • Maximilian I. Ruge
   • Philipp Kickingereder
   • Volker Sturm

   Clinical Study 12 May 2012 Pages: 273 - 283

   

8. Rituximab significantly improves complete response rate in patients with primary CNS lymphoma

   • Tobias Birnbaum
   • Elisabeth Anne Stadler
   • Andreas Straube

   Clinical Study 09 May 2012 Pages: 285 - 291

   

9. Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery

   • Kyung-Il Jo
   • Do-Hoon Lim
   • Jung-Il Lee

   Clinical Study 20 May 2012 Pages: 293 - 299

   

10. Population-based survival data for brain tumors in Korea

    • Kyu-Won Jung
    • Heon Yoo
    • Seung Hoon Lee

    Clinical Study 04 June 2012 Pages: 301 - 307

    

11. Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival

    • Farkhad Manapov
    • Sabine Klöcking
    • Gunther Klautke

    Clinical Study 20 May 2012 Pages: 309 - 314

    

12. Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study

    • James S. Nelson
    • Cecil M. Burchfiel
    • Michael E. Andrew

    Clinical Study 17 May 2012 Pages: 315 - 321

13. Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis

    • Peter Horak
    • Adelheid Wöhrer
    • Christine Marosi

    Clinical Study 20 May 2012 Pages: 323 - 330

    

14. Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

    • Birgit Flechl
    • Michael Ackerl
    • Christine Marosi

    Clinical Study 29 May 2012 Pages: 331 - 339

    

15. Resection of gliomas in the cingulate gyrus: functional outcome and survival

    • Ági Oszvald
    • Johanna Quick
    • Volker Seifert

    Clinical Study 02 June 2012 Pages: 341 - 348

    

16. Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation

    • Zheng Shi
    • Natia Esiashvili
    • Hui-Kuo G. Shu

    Clinical Study 13 June 2012 Pages: 349 - 355

    

17. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood

    • Albert Attia
    • Stephen R. Rapp
    • Edward G. Shaw

    Clinical Study 15 June 2012 Pages: 357 - 363

18. Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients

    • Philipp Kickingereder
    • Mohammad Maarouf
    • Volker Sturm

    Clinical Study 21 June 2012 Pages: 365 - 374

    

19. Successful treatment with a low-dose cisplatin–etoposide regimen for patients with diencephalic syndrome

    • Iacopo Sardi
    • Cecilia Bresci
    • Maura Massimino

    Clinical Study 21 June 2012 Pages: 375 - 383

    

20. Temozolomide or bevacizumab for spinal cord high-grade gliomas

    • Thomas J. Kaley
    • Ijah Mondesire-Crump
    • Igor T. Gavrilovic

    Clinical Study 08 June 2012 Pages: 385 - 389

    

21. Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma

    • Christopher A. Barker
    • Maria Chang
    • Fabio M. Iwamoto

    Clinical Study 12 June 2012 Pages: 391 - 397

    

22. Fatty acid synthase is a predictive marker for aggressiveness in meningiomas

    • Keishi Makino
    • Hideo Nakamura
    • Jun-ichi Kuratsu

    Clinical Study 29 June 2012 Pages: 399 - 404

    

23. Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH

    • Matthieu Talagas
    • Pascale Marcorelles
    • Marc De Braekeleer

    Clinical Study 24 July 2012 Pages: 405 - 413

    

24. DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis

    • André O. von Bueren
    • Joachim Gerss
    • Michael Baudis

    Clinical Study 07 July 2012 Pages: 415 - 423

    

25. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors

    • Kengo Ogura
    • Takashi Mizowaki
    • Masahiro Hiraoka

    Clinical Study 20 June 2012 Pages: 425 - 432

    

26. Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis

    • Jan Kuhnhenn
    • Thomas Kowalski
    • Uwe Schlegel

    Clinical Study 29 June 2012 Pages: 433 - 438